“ADVERSE PREGNANCY OUTCOMES AND MID/ TRIMESTER UTERINE ARTERY DOPPLER IN HIGH-RISK PREGNANCIES” (2022) International Research Journal of Pharmacy, 13(8), pp. 48–52. doi:10.56802/dcbsv314.